Anthera Pharmaceuticals Other Current Liabilities

Anthera Pharmaceuticals (ANTH) currently reports a other current liabilities of $800K as of March 2018. That compares with $3.4M in the prior-year period — down 76.2% year over year. Use the charts on this page to explore Anthera Pharmaceuticals's other current liabilities history and peer comparisons.

Anthera Pharmaceuticals's other current liabilities decreased from $3.4M to $800K — a 76.2% year-over-year decrease (period ending March 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anthera Pharmaceuticals reported $800K in other current liabilities as of March 2018. That compares with $3.4M in the prior-year period — down 76.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $800K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anthera Pharmaceuticals, and consider following ANTH for alerts when major investors trade the stock.

Anthera Pharmaceuticals is classified in the Healthcare sector. On other current liabilities, it currently shows $800K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANTH with unrelated industries.